Wednesday, October 07, 2009
GlaxoSmithKline, Jiangsu Walvax Biotech form joint venture to produce vaccines for China
LONDON - Drugs maker GlaxoSmithKline Plc and Jiangsu Walvax Biotech Company said Tuesday they are forming a joint venture to develop and produce pediatric vaccines for measles, mumps and rubella (MMR) in China....More
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment